STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 59 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $405,000 | -31.4% | 198,534 | 0.0% | 0.02% | -28.6% |
| Q2 2021 | $590,000 | +7.7% | 198,534 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $548,000 | +13.7% | 198,534 | 0.0% | 0.02% | +5.0% |
| Q4 2020 | $482,000 | +15.6% | 198,534 | 0.0% | 0.02% | +5.3% |
| Q3 2020 | $417,000 | -44.4% | 198,534 | 0.0% | 0.02% | -50.0% |
| Q2 2020 | $750,000 | +100.0% | 198,534 | 0.0% | 0.04% | +72.7% |
| Q1 2020 | $375,000 | -9.6% | 198,534 | 0.0% | 0.02% | +15.8% |
| Q4 2019 | $415,000 | – | 198,534 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $15,803,000 | 17.82% |
| Prosight Management, LP | 2,515,072 | $6,011,000 | 3.33% |
| 22NW, LP | 804,410 | $1,923,000 | 2.54% |
| Broadfin Capital, LLC | 2,578,003 | $6,161,000 | 1.14% |
| NEA Management Company, LLC | 4,141,308 | $9,898,000 | 0.82% |
| Opaleye Management Inc. | 490,000 | $1,171,000 | 0.42% |
| PA Capital LLC | 152,977 | $366,000 | 0.36% |
| 683 Capital Management, LLC | 923,700 | $2,208,000 | 0.25% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 414,982 | $992,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,475,000 | $3,525,000 | 0.10% |